Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erastig 4.6mg/24hours transdermal patches
0411000E0BFAAAF
|
Erastig | Rivastigmine | Central Nervous System | No data available |
|
Erastig 9.5mg/24hours transdermal patches
0411000E0BFABAG
|
Erastig | Rivastigmine | Central Nervous System | No data available |
|
Exelon 1.5mg capsules
0411000E0BBAAAA
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 2mg/ml oral solution
0411000E0BBAEAE
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 3mg capsules
0411000E0BBABAB
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 4.5mg capsules
0411000E0BBACAC
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Exelon 6mg capsules
0411000E0BBADAD
|
Exelon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 1.5mg capsules
0411000E0BDAAAA
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 3mg capsules
0411000E0BDABAB
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 4.5mg capsules
0411000E0BDACAC
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 6mg capsules
0411000E0BDADAD
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Nimvastid 1.5mg capsules
0411000E0BCAAAA
|
Nimvastid | Rivastigmine | Central Nervous System | No data available |
|
Nimvastid 3mg capsules
0411000E0BCABAB
|
Nimvastid | Rivastigmine | Central Nervous System | No data available |
|
Nimvastid 4.5mg capsules
0411000E0BCACAC
|
Nimvastid | Rivastigmine | Central Nervous System | No data available |
|
Nimvastid 6mg capsules
0411000E0BCADAD
|
Nimvastid | Rivastigmine | Central Nervous System | No data available |
|
Somniton 4.6mg/24hours transdermal patches
0411000E0BIAAAF
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Somniton 9.5mg/24hours transdermal patches
0411000E0BIABAG
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Voleze 13.3mg/24hours transdermal patches
0411000E0BEACAI
|
Voleze | Rivastigmine | Central Nervous System | No data available |
|
Voleze 4.6mg/24hours transdermal patches
0411000E0BEAAAF
|
Voleze | Rivastigmine | Central Nervous System | No data available |
|
Voleze 9.5mg/24hours transdermal patches
0411000E0BEABAG
|
Voleze | Rivastigmine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.